KCNH1

Across TCGA pan-cancer cohorts, KCNH1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated KCNH1 data layer compared with 22 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher KCNH1 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated KCNH1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, DLBC, and LGG are the cancer types where KCNH1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.945	0.825	.012	26	view →
DLBC	OS	Median	II,III,IV	0.118	0.802	.025	12	view →
LGG	OS	Median	All	0.147	0.799	<.001	7	view →
SARC	OS	Median	All	0.175	0.745	.007	6	view →
SKCM	DFS	Median	III,IV	0.167	0.567	.002	5	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

KCNH1–UCEC (DFS)

Open the UCEC breakdown →